Cazzaniga, Massimo

Publishing since 1990 (Dinosaur)

Has published 56 publications in 20 years

Number of publications published per year by Cazzaniga, Massimo. (Source : PubMed)

Distribution of publications types for Cazzaniga, Massimo. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Bonanni B, Serrano D, Gandini S, Guerrieri-Gonzaga A, Johansson H, Macis D, Cazzaniga M, Luini A, Cassano E, Oldani S, Lien EA, Pelosi G, Decensi A. Randomized biomarker trial of anastrozole or low-dose tamoxifen or their combination in subjects with breast intraepithelial neoplasia.  Clin. Cancer Res.  2009;15;22  
•  Salerno F, Cazzaniga M. Autonomic dysfunction: often present but usually ignored in patients with liver disease.  Liver Int.  2009;29;10  
•  Guerrieri-Gonzaga A, Botteri E, Lazzeroni M, Rotmensz N, Goldhirsch A, Varricchio C, Serrano D, Cazzaniga M, Bassi F, Luini A, Bagnardi V, Viale G, Mora S, Bollani G, Albertazzi E, Bonanni B, Decensi A. Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study.  Ann. Oncol.  2009  
•  Rabie RN, Cazzaniga M, Salerno F, Wong F. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt.  Am. J. Gastroenterol.  2009;104;10  
•  Salerno F, Cazzaniga M. Prevention of early variceal rebleeding adding banding to terlipressin therapy.  Gut  2009;58;9  
•  Cazzaniga M, Dionigi E, Gobbo G, Fioretti A, Monti V, Salerno F. The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome.  J. Hepatol.  2009;51;3  
•  Decensi A, Robertson C, Guerrieri-Gonzaga A, Serrano D, Cazzaniga M, Mora S, Gulisano M, Johansson H, Galimberti V, Cassano E, Moroni SM, Formelli F, Lien EA, Pelosi G, Johnson KA, Bonanni B. Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.  J. Clin. Oncol.  2009;27;23  
•  Tripodi A, Chantarangkul V, Primignani M, Dell'Era A, Clerici M, Iannuzzi F, Aghemo A, Cazzaniga M, Salerno F, Mannucci PM. Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INRliver) can help to implement the INRliver for the calculation of the MELD score.  J. Hepatol.  2009;51;2  
•  Cazzaniga M, Decensi A, Bonanni B, Luini A, Gentilini O. Biomarkers for risk assessment and prevention of breast cancer.  Curr Cancer Drug Targets  2009;9;4  
•  Cazzaniga M, Salerno F, Borroni G, Ceriani R, Stucchi G, Guerzoni P, Casiraghi MA, Tommasini M. Prediction of asymptomatic cirrhosis in chronic hepatitis C patients: accuracy of artificial neural networks compared with logistic regression models.  Eur J Gastroenterol Hepatol  2009;21;6  

[ See timeline ] [ See all publications ]